June 9 (Reuters) - CSPC Pharmaceutical Group Ltd :
* CSPC PHARMACEUTICAL - ANTI-TUMOR NANODRUG "SIROLIMUS FOR INJECTION (ALBUMIN-BOUND)" GETS TRIAL APPROVAL FROM CHINA'S NMPA
Source text for Eikon: Further company coverage:
(Reuters.briefs@thomsonreuters.com)
精彩评论